COURSE CREDITS & HOURS
AMA PRA Category 1 Credits™14 ACPE Credits
COURSE FEES
TARGET AUDIENCE
PROGRAM PURPOSE
evaluate and manage either individually or as part of an interprofessional team, common clinical problems in Nephrology to overall improve patient care. The lectures will help the health care provider(s) be confident in the:
- Approach to evaluating urinalysis and hyponatremia
- Recognition of renovascular hypertension and chronic kidney disease
- Appropriate use of diuretics
- Management of Acute Kidney Injury and poisonings.
Neurology topics:
- Urinalysis - A Window into the Body
- Describe methods of urine collection.
- Interpret physical and dipstick examination of urine.
- Identify microscopic elements in urine sediment.
- Solve clinical cases with abnormal urinalyses
- Understanding Diuretics
- Describe classification and mechanism of action of diuretics
- Review clinical uses and adverse effects
- Define diuretic adaptation and resistance
- Acute Kidney Injury
- Review definition, epidemiology, course and burden of AKI
- Recognize common causes of AKI and identify risk factors
- Discuss the medical management of AKI in the hospitalized patient
- Illustrate with case presentation
- Poisonings in Nephrology
- Discuss different medications and poisonings seen in clinical practice
- Review the clinical presentation of these poisonings
- Describe the management of these poisonings
- Disorders of Water Balance
- Define osmolality and tonicity
- Describe approach to hypo and hypernatremia with case presentations
- Review steps and pitfalls in management of hyponatremia
- Renovascular Hypertension
- Review the pathophysiology of renovascular hypertension
- Describe patients at risk for developing ischemic nephropathy
- Describe diagnostic evaluation of renal artery stenosis
- Discuss management of patients with atherosclerotic renal artery stenosis
- Chronic kidney Disease - A Call to Action
- Facilitate timely testing and intervention in patients at risk for CKD.
- Apply appropriate clinical measures to manage risk and increase patient safety in CKD.
- Comanage and refer to nephrologists, when appropriate, to improve outcomes in CKD.
This purpose of this lecture series is to provide health care providers with the latest tools to evaluate and initiate early treatment for a variety of common rheumatic diseases. By the end of the lecture series, attendees will be able to diagnose and initiate treatment for rheumatoid arthritis, Sjogren's syndrome, polymyalgia rheumatica, giant cell arteritis, gout and pyrophosphate deposition disease. Attendees will also be able to critically analyze lupus serology and explain the poor specificity of the anti-nuclear antibody.
Attendees will be able to describe key clinical findings in scleroderma and discuss the role of an echocardiogram, pulmonary function test and high resolution CT scan of the chest to screen for and identify interstitial lung disease and pulmonary arterial hypertension. Finally, attendees will be able to outline a plan for timing of immunizations and elective surgery for patients who are being treated with immunosuppressive agents for their rheumatic disease.
Rheumatology topics:
- Rheumatoid arthritis: Diagnosis and management
- Diagnose and initiate treatment of rheumatoid arthritis
- Lupus: A case-based approach
- List the most common clinical and laboratory features of lupus
- Sjogren&aposs syndrome: Beyond sicca
- Identify extra-glandular features of Sjogren's syndrome and outline a treatment plan for most common manifestations.
- Scleroderma: A systemic disease
- Describe key clinical features scleroderma.
- Accurately select patients who require more immediate investigations to identify cardiopulmonary disease.
- Polymyalgia rheumatica and giant cell arteritis
- Diagnose polymyalgia rheumatica and initiate treatment.
- Diagnose giant cell arteritis and initiate treatment
- Gout and calcium pyrophosphate deposition disease
- Use the ACR/EULAR guidelines to diagnose and treat gout.
- Differentiate between gout and pyrophosphate deposition disease.
- Rheumatologic medications: what you need to know
- Summarize key potential risks when using disease modifying anti-rheumatic drugs (DMARDs).
- Develop a plan for the appropriate administration of immunizations and timing of surgical procedures in patients who are being treated with DMARDs